title: Electrostatic assembly of a DNA superparamagnetic nano-tool for simultaneous intracellular delivery and in situ monitoring.
abstract: A superparamagnetic γFe(2)O(3) nanocarrier was developed, characterized by spectroscopic methods and evaluated for the delivery of a decoy oligonucleotide (dODN) in human colon carcinoma SW 480 cells. This nanoparticle-dODN bioconjugate (γFe(2)O(3)@dODN) was designed to target the signal transducer and activator of transcription 3, STAT3, a key regulator of cell survival and proliferation. We exploited a simple precipitation-redispersion mechanism for the direct and one-step complexation of a labeled decoy oligonucleotide with iron oxide nanoparticles (NPs). The cell internalization of the decoy γFe(2)O(3)@dODN nanoparticles is demonstrated and suggests the potential for DNA delivery in biological applications. Despite the increasing use of NPs in biology and medicine, convenient methods to quantify them within cells are still lacking. In this work, taking advantage of the nonlinear magnetic behavior of our superparamagnetic NPs, we have developed a new method to quantify in situ their internalization by cells.
  
  
  BACKGROUND
  In this study, the authors demonstrate methods to quantify superparamagnetic nanocarriers within cells, taking advantage of the nonlinear magnetic behavior of the studied NPs.
authors.affiliation: Laboratoire CSPBAT, UMR 7244 CNRS, Université Paris 13, Bobigny, France.
authors.forename: Frédéric
authors.initials: F
authors.lastname: Geinguenaud
authors.forename: Inès
authors.initials: I
authors.lastname: Souissi
authors.forename: Remi
authors.initials: R
authors.lastname: Fagard
authors.forename: Laurence
authors.initials: L
authors.lastname: Motte
authors.forename: Yoann
authors.initials: Y
authors.lastname: Lalatonne
mesh_terms: D045744:Cell Line, Tumor; D003110:Colonic Neoplasms / Q000235:genetics* / Q000628:therapy; D004247:DNA / Q000008:administration & dosage* / Q000235:genetics; D004337:Drug Carriers / Q000737:chemistry; D016503:Drug Delivery Systems / Q000379:methods*; D005290:Ferric Compounds / Q000737:chemistry*; D015316:Genetic Therapy; D006801:Humans; D008280:Magnetics / Q000379:methods; D059346:Magnets / Q000737:chemistry*; D053758:Nanoparticles / Q000737:chemistry*; D009841:Oligonucleotides / Q000008:administration & dosage / Q000235:genetics; D050796:STAT3 Transcription Factor / Q000235:genetics
chemical_list: D004337:Drug Carriers; D005290:Ferric Compounds; D009841:Oligonucleotides; D050796:STAT3 Transcription Factor; C000499:ferric oxide; D004247:DNA